Nanoplatform-based cellular reactive oxygen species regulation for enhanced oncotherapy and tumor resistance alleviation  

作　　者：Meifang Wang Ping’an Ma Jun Lin 

机构地区：[1]State Key Laboratory of Rare Earth Resource Utilization,Changchun Institute of Applied Chemistry,Chinese Academy of Sciences,Changchun 130022,China

出　　处：《Chinese Chemical Letters》2023年第9期85-99,共15页中国化学快报（英文版）

基　　金：financially supported by the National Key Research and Development Program of China(No.2022YFB3804500);the National Natural Science Foundation of China(NSFC,Nos.51929201 and 52102354);the projects for Science and Technology Development Plan of Jilin province(Nos.20210402046GH and 20220508089RC)。

摘　　要：The cancer cells realize their proliferation and metastasis activities based on the special redox adaptation to increased reactive oxygen species(ROS)level,which inversely makes them sensitive to external interference with their redox state.In view of this,in recent decades,researchers have made great efforts to construct a series of novel nanoplatform-based ROS-mediated cancer therapies through increasing ROS generation and inhibiting the ROS elimination.Besides,the multidrug resistance and thermoresistance of tumor are closely related to tumor redox state.Recently,numerous works have shown that ROS regulation in cancer cells can intervene in the expression,function and stability of related proteins to achieve reversal of tumor resistance.In this review,the recent researches about ROS-regulating nanoagents on cancer therapy and tumor resistance alleviation have been well summarized.Finally,the challenges and research directions of ROS-regulating nanoagents for future clinical translation are also discussed.

关 键 词：Nanoagents ROS regulation ROS-mediated cancer therapy Multidrug resistance THERMORESISTANCE 

分 类 号：TQ460.1[化学工程—制药化工] TB383.1[一般工业技术—材料科学与工程]